CompoAtlas

Nutritech Ginkgo Biloba 60mg Tablets

Natural health product licensed in Canada

Other names
GFU Ginkgo Biloba 60mg Tablets, Golden Leaf Ginkgo Biloba 60mg Tablets, Miette Ginkgo Biloba 60mg Tablets, Sante Ginkgo Biloba 60mg Tablets
Licence holder
Nutritech Explorer (Canada) Inc.
NPN or DIN-HM
80061171
Status
Active licence
Licence date
22 May 2015
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Eleutherococcus senticosus

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 20:1

Dry plant equivalent : 1,400 milligramme

70 milligrammeNot calculated
Ginkgo biloba

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 50:1

Dry plant equivalent : 3,000 milligramme

Potency : 6 % Terpene lactones

60 milligrammeNot calculated
Ginkgo biloba

Source : Feuille

Potency : 24 % Flavonoid glycosides

Not specifiedNot calculated
Acide L-glutamique

Source : Acide glutamique

50 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Amidon de maïs, Stéarate de magnésium, Phosphate dicalcique, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Comprimé2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to enhance cognitive function in adults. Used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80061171

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Eleutherococcus senticosus
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 October 2025

  • Ginkgo biloba
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line